Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1999 1
2006 1
2007 1
2008 1
2010 1
2013 1
2014 1
2016 1
2017 1
2018 3
2019 2
2020 2
2021 3
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical Trial.
Rastogi A, Kulkarni SA, Agarwal S, Akhtar M, Arsule S, Bhamre S, Bhosle D, Desai S, Deshmukh M, Giriraja KV, Jagannath J, Kashiva RY, Kesavan R, Khandelwal D, Kolte S, Kongara S, Darivemula AK, Madhusudan C, Pyare Saheb Qureshi MAH, Ramu M, Rathod G, Yalamanchi SR, Shakya S, Shetty P, Singh S, Deshpande SK, Viswanathan V, Unnikrishnan AG. Rastogi A, et al. Among authors: deshpande sk. JAMA Netw Open. 2023 May 1;6(5):e2311509. doi: 10.1001/jamanetworkopen.2023.11509. JAMA Netw Open. 2023. PMID: 37184839 Free article. Clinical Trial.
Use of secukinumab in erythrodermic psoriasis: A single center experience.
Bhatnagar A, Singh GK, Deshpande SK, Mitra B, Mitra D, Agrawal V, Reddy S, Patil C, Sandhu S. Bhatnagar A, et al. Among authors: deshpande sk. Med J Armed Forces India. 2023 Dec;79(Suppl 1):S6-S12. doi: 10.1016/j.mjafi.2021.07.009. Epub 2021 Oct 11. Med J Armed Forces India. 2023. PMID: 38144608
Novel Topical Esmolol Hydrochloride (Galnobax) for Diabetic Foot Wound: Phase 1/2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Parallel-Group Study.
Rastogi A, Kulkarni SA, Deshpande SK, Driver V, Barman H, Bal A, Deshmukh M, Nair H. Rastogi A, et al. Among authors: deshpande sk. Adv Wound Care (New Rochelle). 2023 Aug;12(8):429-439. doi: 10.1089/wound.2022.0093. Epub 2022 Nov 16. Adv Wound Care (New Rochelle). 2023. PMID: 36245145 Clinical Trial.
26 results